BioTroy Therapeutics

Shanghai, China · Founded 2020 · Privately Held (backing)

Developer of target discovery pharmaceutical technology designed to promote the development of new first-in-class drugs. BioTroy Therapeutics is based in Shanghai, China and was founded in 2020. It has raised $54 million.

Last price · $/share
—
Implied valuation
—
Total raised
$54.0M
Last round
—

Who backs BioTroy Therapeutics?

13 investors
InvestorType
Lapam CapitalVenture capital
Co-Win VenturesOther
Pudong CapitalOther
Shanghai Healthcare CapitalPE / buyout
Shangshi Venture InvestmentOther
Atlatl (Shanghai)—
BFC Group (Shanghai)—
Lang Run Capital—
Shanghai Science and Technology Innovation Center Equity Investment Fund Management—
Shanghai Shangshi Capital Management—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

BioTroy Therapeutics investors

13 investors are on record for BioTroy Therapeutics, including Lapam Capital, Co-Win Ventures, Pudong Capital and Shanghai Healthcare Capital.

Free account
More of BioTroy Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch BioTroy Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like BioTroy Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View